ISSCR News


New Podcast Episode. Movin’ On Out: Mobilizing HSCs from the Bone Marrow
Announcements Megan Koch Announcements Megan Koch

New Podcast Episode. Movin’ On Out: Mobilizing HSCs from the Bone Marrow

Hematopoietic stem cells (HSCs) normally reside in the bone marrow niche but can traffic across the bone marrow endothelium into the bloodstream to populate different niches. This process of HSC mobilization from the bone marrow to the blood, is an increasingly favored procedure to obtain HSCs for hematopoietic cell transplantation therapy. Though mobilization is robust in many donors due to years of refined protocols and drug combinations, the process remains difficult or contraindicated among substantial patient subgroups. Using the current standard of care, up to 30% of patients fail to mobilize HSCs and some patients cannot tolerate the current mobilization procedures. Today’s guests will discuss their research using vascular endothelial growth factor, known as VEGF, as an alternative method of mobilization, the mechanisms underlying it, and the implications for improving patient outcomes.

Read More
The ISSCR Holds Inaugural Regulatory Meeting with Japan’s Pharmaceuticals and Medical Devices Agency and South Korea’s Ministry of Food and Drug Safety 
Policy, Announcements Kym Kilbourne Policy, Announcements Kym Kilbourne

The ISSCR Holds Inaugural Regulatory Meeting with Japan’s Pharmaceuticals and Medical Devices Agency and South Korea’s Ministry of Food and Drug Safety 

On 7 November 2024, the International Society for Stem Cell Research (ISSCR) held its first meeting with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) and Korea’s Ministry of Food and Drug Safety (MFDS). Held at PMDA’s Tokyo headquarters, the meeting brought together senior officials from PMDA and MFDS alongside ISSCR leaders based in Japan, Korea, and the United States.

At this inaugural meeting, participants convened to discuss key topics related to the:

1) manufacture of human Pluripotent Stem Cell (hPSC) banks as starting materials for allogeneic, PSC-based therapies, and
2) genetic assessment of hPSCs, 3) jurisdictional differences in guidelines for biological Ancillary Materials (AM).

The participants also had the opportunity to gain insights into the regulatory approaches of the PMDA and MFDS regarding PSC-based products.  

Read More
ISSCR Joins Coalition Effort to Support Advocacy for NIH Funding
Announcements, Policy Kym Kilbourne Announcements, Policy Kym Kilbourne

ISSCR Joins Coalition Effort to Support Advocacy for NIH Funding

The ISSCR is proud to join a broad coalition of scientific societies in affirming the essential role of the National Institutes of Health in advancing biomedical discovery and sustaining a robust research enterprise. As part of this effort, ISSCR members in the targeted states of Kansas, North Carolina, Pennsylvania, and Utah have been invited to share stories that illustrate the vital importance of research investment. Additional opportunities for members in all states will be available in September. This campaign is led by our alliance partner, Research!America

Read More
The ISSCR Calls for Science Serving the Public Good to be of the Highest Quality and Integrity
Policy, Announcements Kym Kilbourne Policy, Announcements Kym Kilbourne

The ISSCR Calls for Science Serving the Public Good to be of the Highest Quality and Integrity

“The ISSCR joined more than 90 scientific, academic, and professional organizations to emphasize that science serving the public good should be of the highest quality, integrity, and utility. In a letter sent to White House Office of Science and Technology Policy Director Michael Kratsios, signatories urged policymakers to recognize that any efforts to strengthen scientific integrity, including those outlined in the recent Executive Order “Restoring Gold Standard Science”, must build upon, rather than undermine, the existing foundational pillars of gold standard science that have driven decades of scientific and technological progress. These principles, including empirical rigor, objectivity, peer review, and reproducibility have been central to the advancement of stem cell science and the development of cell-based therapies.

Read More

Receive ISSCR Press Releases

Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications

Subscribe to ISSCR News.

Each month, ISSCR delivers scientific, policy, and community to your inbox .